Compare DraftKings Inc (DKNG) vs Ginkgo Bioworks Holdings Inc (DNA) Price & Performance

DraftKings IncTrade

Ginkgo Bioworks Holdings IncTrade

Price performance (Past 24H)

Key statistics

DraftKings Inc vs Ginkgo Bioworks Holdings Inc — how do they compare? DraftKings Inc trades at $25.14 (market cap $12.05B), while Ginkgo Bioworks Holdings Inc trades at $7.51 (market cap $515.15M). The key difference: DraftKings Inc is far larger — about 23.4× Ginkgo Bioworks Holdings Inc's market cap. Which is the better fit depends on your goals.

	DKNG	DNA
Market Cap	$12.05B	$515.15M
Sector	Consumer Cyclical	Health
52-Week High	$48.23	$16.14
52-Week Low	$20.72	$5.48
Enterprise Value	$12.98B	$617.10M

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

DraftKings Inc

No Aura AI signal available yet.

Ginkgo Bioworks Holdings Inc

Ginkgo Bioworks (DNA) trades at $7.97, down 6.24% today, reflecting ongoing operational challenges. The company reported Q2 2026 revenue of $20 million, a 48% year-over-year decline, as it shifts focus to autonomous lab systems. Despite beating EPS expectations in two of the last three quarters, net losses remain substantial with a -219.6% margin. Technical indicators show bearish momentum with support at $7 and resistance at $9.

DNA faces significant headwinds with declining revenue and persistent losses, though analyst sentiment is mixed with 45% buy ratings. The pivot to new business lines creates uncertainty, while cash burn and competitive pressures present substantial risks. Upside depends on successful execution of the strategic shift and path to profitability.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

DKNG

DraftKings faces decline as prediction markets outpace traditional sportsbooks, shares down 30% YTD.Seeking Alpha · 1 day agoBearish DraftKings Q2 misses earnings but shows strong growth in Predictions platform, stock remains a hold ahead of NFL season.24/7 Wall Street · 1 day agoNeutral DraftKings' prediction markets drive rapid growth, reshaping its national sports betting strategy.PYMNTS · 4 days agoBullish View details →

DNA

View details →

About DraftKings Inc

DraftKings Inc is a digital sports entertainment and gaming company. The company provides users with daily fantasy sports (DFS), sports betting, and iGaming opportunities and is also involved in the design & development of sports betting and casino gaming platform software for online and retail sportsbook and casino gaming products. It operates in two segments: Business-to-consumer(B2C) and Business-to-Business(B2B), of which the vast majority of its revenue comes from the B2C segment. Geographically, it derives most of its revenue from the United States.

About Ginkgo Bioworks Holdings Inc

Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.